Finance

Lists
Why is CVRX down 3.60%?
Dive Deeper
CVRX:NASDAQ
CVRx Inc
$0.61
-3.60%
(-0.023) 1D
$0.59
-2.86% (-0.017)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CVRX...
Open
$0.63
High
$0.66
Low
$0.60
Mkt. cap
17.30M
Avg. vol.
740.21K
Volume
759.89K
52-wk high
$10.28
52-wk low
$0.60
EPS
-$2.00
Beta
0.81
Shares outstanding
28.48M
No. of employees
223
Open
$0.63
High
$0.66
Low
$0.60
Mkt. cap
17.30M
Avg. vol.
740.21K
Volume
759.89K
52-wk high
$10.28
52-wk low
$0.60
EPS
-$2.00
Beta
0.81
Shares outstanding
28.48M
No. of employees
223
News stories
From web sources and news partners
About CVRx Inc
CEO-
Employees223
Founded2000
HeadquartersMinneapolis, Minnesota, United States
SectorHealth Care
IndustryMedical device
Websitebarostim.com
Analyst ratings
Based on 6 analysts giving stock ratings to CVRX in the past 3 months
Hold
Buy
1
Hold
5
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for CVRX in the last 3 months.
Highest
Current $0.61
$5.00 (+723.18%)
Average
$2.25 (+270.43%)
Lowest
$1.25 (+105.80%)
Analyst
Recommendation
Action
Price target
Projected
Date
William Plovanic
Canaccord Genuity
Hold
Downgraded
$2.00
+229.3%
11/09/2026
Chase Knickerbocker
Craig-Hallum
Hold
Maintained
$1.25
+105.8%
11/06/2026
Matthew O'Brien
Piper Sandler
Hold
Maintained
$1.50
+147%
11/06/2026
Frank Takkinen
Lake Street
Hold
Maintained
$1.50
+147%
11/06/2026
Brandon Vazquez
William Blair
Hold
Downgraded
-
-
11/05/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$5.00
+723.2%
08/17/2026
Daniel Brims
Lake Street
Buy
Reiterated
$14.00
+2,204.9%
05/12/2026
Robbie Marcus
J.P. Morgan
Sell
Reiterated
$6.00
+887.8%
05/12/2026
Thomas Flaten
Lake Street
Buy
Reiterated
$14.00
+2,204.9%
05/05/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
-$0.52 / -$0.50
-3.40%miss
Revenue / Est. (USD)
13.83M / 13.91M
-0.55%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
16.02M
14.77M
15.70M
13.83M
Cost of goods sold
2.20M
1.89M
1.98M
1.83M
Cost of revenue
2.20M
1.89M
1.98M
1.83M
Research and development expenses
3.00M
3.08M
3.13M
2.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.01M
21.96M
23.62M
22.39M
Operating expense
25.01M
25.04M
26.75M
25.04M
Total operating expenses
27.21M
26.93M
28.73M
26.88M
Operating income
-11.18M
-12.16M
-13.02M
-13.04M
Other non operating income
660.00K
593.00K
560.00K
488.00K
EBT including unusual items
-11.94M
-13.12M
-14.04M
-14.16M
EBT excluding unusual items
-11.94M
-13.12M
-14.04M
-14.16M
Income tax expense
-7.00K
1.00K
3.00K
-1.00K
Effective tax rate
0.06%
-0.01%
-0.02%
0.01%
Other operating expenses
-
-
-
-
Net income
-11.93M
-13.12M
-14.04M
-14.16M
Net profit margin
-74.48%
-88.83%
-89.42%
-102.39%
Earnings per share
-0.46
-0.50
-0.53
-0.52
Interest and investment income
-
-
-
-
Interest expense
-1.42M
-1.55M
-1.58M
-1.61M
Net interest expenses
-1.42M
-1.55M
-1.58M
-1.61M
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.00M
-11.96M
-12.81M
-12.82M
Gain or loss from assets sale
86.00K
1.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps